BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UK-PBC - ECPv4.5.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UK-PBC
X-ORIGINAL-URL:https://www.uk-pbc.com
X-WR-CALDESC:Events for UK-PBC
BEGIN:VEVENT
DTSTART;TZID=UTC+0:20160303T083000
DTEND;TZID=UTC+0:20160304T123000
DTSTAMP:20260517T072940
CREATED:20151229T140402Z
LAST-MODIFIED:20160629T133354Z
UID:1556-1456993800-1457094600@www.uk-pbc.com
SUMMARY:AASLD/FDA Conference on Trial Design and Endpoints for Clinical Trial in Adults and Children with Primary Sclerosing
DESCRIPTION:The goal of this workshop is to promote successful and meaningful clinical trials and drug development in Primary Sclerosing Cholangitis (PSC) by identifying and clarifying what is currently known to determine the best trial designs\, populations and endpoints.
URL:https://www.uk-pbc.com/event/aasldfda-conference-on-trial-design-and-endpoints-for-clinical-trial-in-adults-and-children-with-primary-sclerosing/
LOCATION:Silver Spring\, MD\, MD 20903\, United States
ATTACH;FMTTYPE=image/png:https://www.uk-pbc.com/wp-content/uploads/2015/12/AASLD-253-163.png
END:VEVENT
END:VCALENDAR